A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia after Major Hepatopancreatobiliary Surgery

Thomas A. Aloia, Bradford J. Kim, Yun Shin Segraves-Chun, Juan P. Cata, Mark J. Truty, Qiuling Shi, Alexander Holmes, Jose M. Soliz, Keyuri U. Popat, Thomas F. Rahlfs, Jeffrey E. Lee, Xin Shelley Wang, Jeffrey S. Morris, Vijaya N.R. Gottumukkala, Jean Nicolas Vauthey

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Objectives: The primary objective of this randomized trial was to compare thoracic epidural analgesia (TEA) to intravenous patient-controlled analgesia (IV-PCA) for pain control over the first 48 hours after hepatopancreatobiliary (HPB) surgery. Secondary endpoints were patient-reported outcomes, total narcotic utilization, and complications. Background: Although adequate postoperative pain control is critical to patient and surgeon success, the optimal analgesia regimen in HPB surgery remains controversial. Methods: Using a 2.5:1 randomization strategy, 140 patients were randomized to TEA (N = 106) or intravenous patient-controlled analgesia (N = 34). Patient-reported pain was measured on a Likert scale (0-10) at standard time intervals. Cumulative pain area under the curve was determined using the trapezoidal method. Results: Between the study groups key demographic, comorbidity, clinical, and operative variables were equivalently distributed. The median area under the curve of the postoperative time 0- to 48-hour pain scores was lower in the TEA group (78.6 vs 105.2 pain-hours, P = 0.032) with a 35% reduction in patients experiencing ≥7/10 pain (43% vs 62%, P = 0.07). Patient-reported outcomes and total opiate use further supported the benefit of TEA on patient experience. Anesthesia-related events requiring change in analgesic therapy were comparable (12.2% vs 2.9%, respectively, P = 0.187). Grade 3 or higher surgical complications (6.6% vs 9.4%), median length of stay (6 days vs 6 days), readmission (1.9% vs 3.1%), and return to the operating room (0.9% vs 3.1%) were similar (all P > 0.05). There were no mortalities in either group. Conclusions: In major HPB surgery, TEA provides a superior patient experience through improved pain control and less narcotic use, without increased length of stay or complications.

Original languageEnglish (US)
Pages (from-to)545-554
Number of pages10
JournalAnnals of surgery
Volume266
Issue number3
DOIs
StatePublished - Sep 1 2017

Keywords

  • hepatectomy
  • pain management
  • pancreaticoduodenectomy
  • patient-reported outcomes
  • quality of life

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia after Major Hepatopancreatobiliary Surgery'. Together they form a unique fingerprint.

  • Cite this

    Aloia, T. A., Kim, B. J., Segraves-Chun, Y. S., Cata, J. P., Truty, M. J., Shi, Q., Holmes, A., Soliz, J. M., Popat, K. U., Rahlfs, T. F., Lee, J. E., Wang, X. S., Morris, J. S., Gottumukkala, V. N. R., & Vauthey, J. N. (2017). A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia after Major Hepatopancreatobiliary Surgery. Annals of surgery, 266(3), 545-554. https://doi.org/10.1097/SLA.0000000000002386